154 related articles for article (PubMed ID: 30383785)
1. Macrophage Inhibitory Factor-1 (MIF-1) controls the plasticity of multiple myeloma tumor cells.
Joseph D; Gonsky JP; Blain SW
PLoS One; 2018; 13(11):e0206368. PubMed ID: 30383785
[TBL] [Abstract][Full Text] [Related]
2. The role of SH3GL3 in myeloma cell migration/invasion, stemness and chemo-resistance.
Chen R; Zhao H; Wu D; Zhao C; Zhao W; Zhou X
Oncotarget; 2016 Nov; 7(45):73101-73113. PubMed ID: 27683032
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells.
Fuhler GM; Baanstra M; Chesik D; Somasundaram R; Seckinger A; Hose D; Peppelenbosch MP; Bos NA
Exp Cell Res; 2010 Jul; 316(11):1816-28. PubMed ID: 20307537
[TBL] [Abstract][Full Text] [Related]
4. Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.
Zheng Y; Wang Q; Li T; Qian J; Lu Y; Li Y; Bi E; Reu F; Qin Y; Drazba J; Hsi E; Yang J; Cai Z; Yi Q
J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27381622
[TBL] [Abstract][Full Text] [Related]
5. Cell surface syndecan-1 contributes to binding and function of macrophage migration inhibitory factor (MIF) on epithelial tumor cells.
Pasqualon T; Lue H; Groening S; Pruessmeyer J; Jahr H; Denecke B; Bernhagen J; Ludwig A
Biochim Biophys Acta; 2016 Apr; 1863(4):717-26. PubMed ID: 26852939
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells.
Kawano Y; Kikukawa Y; Fujiwara S; Wada N; Okuno Y; Mitsuya H; Hata H
Int J Oncol; 2013 Dec; 43(6):1809-16. PubMed ID: 24126540
[TBL] [Abstract][Full Text] [Related]
7. Clonogenic multiple myeloma cells have shared stemness signature associated with patient survival.
Reghunathan R; Bi C; Liu SC; Loong KT; Chung TH; Huang G; Chng WJ
Oncotarget; 2013 Aug; 4(8):1230-40. PubMed ID: 23985559
[TBL] [Abstract][Full Text] [Related]
8. CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.
Wu D; Guo X; Su J; Chen R; Berenzon D; Guthold M; Bonin K; Zhao W; Zhou X
Biochim Biophys Acta; 2015 Feb; 1853(2):338-47. PubMed ID: 25450979
[TBL] [Abstract][Full Text] [Related]
9. Myeloma-derived macrophage inhibitory factor regulates bone marrow stromal cell-derived IL-6 via c-MYC.
Piddock RE; Marlein CR; Abdul-Aziz A; Shafat MS; Auger MJ; Bowles KM; Rushworth SA
J Hematol Oncol; 2018 May; 11(1):66. PubMed ID: 29769142
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138(-) CD34(-) tumor stem-like cells in multiple myeloma-bearing mice.
Yang C; Wang J; Chen D; Chen J; Xiong F; Zhang H; Zhang Y; Gu N; Dou J
Int J Nanomedicine; 2013; 8():1439-49. PubMed ID: 23610522
[TBL] [Abstract][Full Text] [Related]
11. Effect of levamisole on expression of CD138 and interleukin-6 in human multiple myeloma cell lines.
Nageshwari B; Merugu R
Indian J Cancer; 2017; 54(3):566-571. PubMed ID: 29798960
[TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.
Ohta S; Misawa A; Fukaya R; Inoue S; Kanemura Y; Okano H; Kawakami Y; Toda M
J Cell Sci; 2012 Jul; 125(Pt 13):3210-20. PubMed ID: 22454509
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury.
Zhou Y; Guo W; Zhu Z; Hu Y; Wang Y; Zhang X; Wang W; Du N; Song T; Yang K; Guan Z; Wang Y; Guo A
J Neuroinflammation; 2018 Sep; 15(1):253. PubMed ID: 30180853
[TBL] [Abstract][Full Text] [Related]
15. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
Wang Z; Xue Y; Wang P; Zhu J; Ma J
Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642
[TBL] [Abstract][Full Text] [Related]
16. The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype.
Yaccoby S
Clin Cancer Res; 2005 Nov; 11(21):7599-606. PubMed ID: 16278377
[TBL] [Abstract][Full Text] [Related]
17. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.
Matsui W; Wang Q; Barber JP; Brennan S; Smith BD; Borrello I; McNiece I; Lin L; Ambinder RF; Peacock C; Watkins DN; Huff CA; Jones RJ
Cancer Res; 2008 Jan; 68(1):190-7. PubMed ID: 18172311
[TBL] [Abstract][Full Text] [Related]
18. [Effect of 2-methoxyestradiol on differentiation of primary myeloma cells].
Gao WR; Hou J; Xiong H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):262-6. PubMed ID: 16638193
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.
Simpson KD; Templeton DJ; Cross JV
J Immunol; 2012 Dec; 189(12):5533-40. PubMed ID: 23125418
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma.
Ren Y; Tsui HT; Poon RT; Ng IO; Li Z; Chen Y; Jiang G; Lau C; Yu WC; Bacher M; Fan ST
Int J Cancer; 2003 Oct; 107(1):22-9. PubMed ID: 12925952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
